COMPANY

Surmodics

HQ: Eden Prairie, MN source · surmodics.com ↗ · Midwest

Status: Acquired, now part of GTCR · How status works

FDA-cleared device company Past trials only

3 open jobs · last seen Oct 23, 2026 · 58 sources

Keywords: analytical services Peripheral Arterial Disease Acute Limb Ischemia Peripheral Vascular Disease Peripheral Artery Disease Femoropopliteal Artery Occlusion Hemodialysis Access Failure Peripheral Vascular Occlusive Disease Critical Lower Limb Ischemia Diabetic Macular Edema Peripheral Vascular Diseases fibrosis thrombosis SurVeil Drug Coated Balloon Pounce Thrombectomy System Pounce Venous Thrombectomy System SUNDANCE™ Drug Coated Balloon

Profile checked Oct 10, 2026

3Open jobs 7Trials (company is sponsor)50NIH grants

Hiring

Title	Location (from posting)	Employer posted	First seen
HR Generalist	Horsham, Pennsylvania, United States	Oct 20, 2026	Oct 21, 2026
Operator 1	Eden Prairie, Minnesota, United States	Oct 20, 2026	Oct 21, 2026
Technician 2	Eden Prairie, Minnesota, United States	Oct 8, 2026	Oct 9, 2026

See all 3 jobs

Timeline

Oct 9, 2026 Board tracked Radar started tracking this company’s job board (3 open jobs at last check). source ↗
Apr 1, 2025 Trial start Not phased (device or behavioral study): SurmodiCs Pounce Venous THrOMbectomy System Post Market Clinical Follow Up Study source ↗
Apr 18, 2023 Trial start —: Pounce™ Thrombectomy System Retrospective Registry source ↗
Jun 29, 2020 Trial start Not phased (device or behavioral study): Safety and Feasibility of Surmodics SUNDANCE™ Drug Coated Balloon source ↗
Dec 5, 2018 Trial start Not phased (device or behavioral study): Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (AVess FIH) source ↗
Oct 23, 2017 Trial start Not phased (device or behavioral study): Safety and Efficacy of the SurVeil™ Drug-Coated Balloon source ↗
Apr 5, 2016 Trial start Not phased (device or behavioral study): Safety and Feasibility of SurModics SurVeil (TM) Drug Coated Balloon source ↗
2005-06 Trial start Phase 1: Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema source ↗

Open jobs 3

Title	Location (from posting, not HQ)	Employer posted	First seen	Level
HR Generalist	Horsham, Pennsylvania, United States	Oct 20, 2026	Oct 21, 2026	Not stated
Operator 1	Eden Prairie, Minnesota, United States	Oct 20, 2026	Oct 21, 2026	Not stated
Technician 2	Eden Prairie, Minnesota, United States	Oct 8, 2026	Oct 9, 2026	Mid

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

Clinical trials (lead sponsor) 7

Record	Title	Phase	Status	Start	Primary completion
NCT05868161	Pounce™ Thrombectomy System Retrospective Registry	Not listed	Recruiting	Apr 18, 2023	May 31, 2026 (estimated)
NCT03241459	Safety and Efficacy of the SurVeil™ Drug-Coated Balloon	Not phased (device or behavioral study)	Completed	Oct 23, 2017	Sep 15, 2020 (actual)
NCT03734679	Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (AVess FIH)	Not phased (device or behavioral study)	Completed	Dec 5, 2018	Feb 19, 2020 (actual)
NCT05600816	SurmodiCs Pounce Venous THrOMbectomy System Post Market Clinical Follow Up Study	Not phased (device or behavioral study)	Unknown status (ClinicalTrials.gov)	Apr 1, 2025	Oct 1, 2025 (estimated)
NCT04107298	Safety and Feasibility of Surmodics SUNDANCE™ Drug Coated Balloon	Not phased (device or behavioral study)	Completed	Jun 29, 2020	Aug 23, 2021 (actual)
NCT00915837	Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema	Phase 1	Completed	2005-06	2009-04 (actual)
NCT02648620	Safety and Feasibility of SurModics SurVeil (TM) Drug Coated Balloon	Not phased (device or behavioral study)	Completed	Apr 5, 2016	2017-01 (actual)

NIH awards 50

Annual award amounts. Total $18.1M.

Jun 30, 2003 NIH award 2R44HL066933-02 FY2003: $366,024 awarded for that fiscal year; activity R44 (SBIR); PI GUIRE, PATRICK E; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. Latent Reactive Groups for Biomaterials source ↗
Sep 27, 2002 NIH award 3R43HL066933-01A1S1 FY2002: $30,745 awarded for that fiscal year; activity R43 (SBIR); PI GUIRE, PATRICK E; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. Latent-Reactive Reagents for Biomaterial source ↗
Jul 29, 2002 NIH award 5R44GM058342-03 FY2002: $371,485 awarded for that fiscal year; activity R44 (SBIR); PI GUIRE, PATRICK E; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. Photoreactive Self-Assembled Monolayers source ↗
Sep 28, 2001 NIH award 2R44GM058342-02A1 FY2001: $378,711 awarded for that fiscal year; activity R44 (SBIR); PI GUIRE, PATRICK E; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. Photoreactive Self-Assembled Monolayers source ↗
Aug 6, 2001 NIH award 1R43HL066933-01A1 FY2001: $67,756 awarded for that fiscal year; activity R43 (SBIR); PI GUIRE, PATRICK E; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. Latent-Reactive Reagents for Biomaterial Su source ↗
Sep 14, 2000 NIH award 1R43DE012578-01A1 FY2000: $99,998 awarded for that fiscal year; activity R43 (SBIR); PI DURAN, LISE W; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. MICROBICIDAL COATINGS FOR DENTAL UNIT WATERLIN source ↗
Sep 21, 1998 NIH award 1R43DK054087-01 FY1998: $99,774 awarded for that fiscal year; activity R43 (SBIR); PI DUQUETTE, PETER H; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. PHOTOINITIATED CONFORMAL ISLET ENCAPSULATION source ↗
Aug 31, 1998 NIH award 1R43GM058342-01 FY1998: $99,260 awarded for that fiscal year; activity R43 (SBIR); PI GUIRE, PATRICK E; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. PHOTOREACTIVE SELF ASSEMBLED MONOLAYERS source ↗
Aug 24, 1998 NIH award 1R43AR044610-01A1 FY1998: $99,992 awarded for that fiscal year; activity R43 (SBIR); PI CLAPPER, DAVID L; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. IN SITU PHOTO CROSSLINKED COLLAGEN/GF FOR B source ↗
Aug 21, 1998 NIH award 5R44AI035343-03 FY1998: $350,560 awarded for that fiscal year; activity R44 (SBIR); PI SWANSON, MELVIN J; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. REAGENTS AND METHODS FOR AFFINITY PURIFICAT source ↗
Jul 22, 1998 NIH award 5R44HL049681-03 FY1998: $371,650 awarded for that fiscal year; activity R44 (SBIR); PI DUQUETTE, PETER H; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. IMMOBILIZED SULFONATES FOR REDUCED THROMBOG source ↗
Jun 17, 1998 NIH award 5R44AI034225-03 FY1998: $392,905 awarded for that fiscal year; activity R44 (SBIR); PI SWANSON, MELVIN J; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. PATHOGEN PROTECTIVE COATINGS FOR MEDICAL DE source ↗
May 21, 1998 NIH award 1R43DK052756-01A2 FY1998: $99,342 awarded for that fiscal year; activity R43 (SBIR); PI GUIRE, PATRICK E; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. PATTERNED IMMOBILIZATION OF BIOTIN ON GLASS source ↗
Sep 19, 1997 NIH award 2R44AI035343-02 FY1997: $338,629 awarded for that fiscal year; activity R44 (SBIR); PI SWANSON, MELVIN J; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. REAGENTS AND METHODS FOR AFFINITY PURIFICAT source ↗
Aug 19, 1997 NIH award 2R44HL049681-02A3 FY1997: $348,536 awarded for that fiscal year; activity R44 (SBIR); PI DUQUETTE, PETER H; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. IMMOBILIZED SULFONATES FOR REDUCED THROMB source ↗
Jul 28, 1997 NIH award 1R43HL057691-01A1 FY1997: $99,795 awarded for that fiscal year; activity R43 (SBIR); PI GUIRE, PATRICK E; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. PHOTOREACTIVE GOLD SURFACE--STREPTAVIDIN BA source ↗
Jul 24, 1997 NIH award 2R44AI034225-02A3 FY1997: $329,981 awarded for that fiscal year; activity R44 (SBIR); PI SWANSON, MELVIN J; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. PATHOGEN PROTECTIVE COATINGS FOR MEDICAL source ↗
Jun 18, 1997 NIH award 5R44HL050224-03 FY1997: $426,419 awarded for that fiscal year; activity R44 (SBIR); PI DUQUETTE, PETER H; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. IMMOBILIZED FATTY ACIDS FOR REVERSIBLE ALBU source ↗
May 13, 1997 NIH award 1R43AR044758-01 FY1997: $98,914 awarded for that fiscal year; activity R43 (SBIR); PI DURAN, LISE W; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. ANTIINFECTIVE COATINGS FOR ORTHOPEDIC DEVICES source ↗
Feb 25, 1997 NIH award 1R43HD034318-01A1 FY1997: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI CLAPPER, DAVID L; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. PHOTOIMMOBILIZED CATHETER COATINGS TO INHI source ↗
Sep 30, 1996 NIH award 1R43AR044291-01 FY1996: $98,541 awarded for that fiscal year; activity R43 (SBIR); PI DUQUETTE, PETER H; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. CONFORMABLE POLYMERIC DRESSING FOR SKIN ULCE source ↗
Aug 27, 1996 NIH award 5R44CA055484-03 FY1996: $307,369 awarded for that fiscal year; activity R44 (SBIR); PI CLAPPER, DAVID L; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. SURFACE MODIFICATION TO IMPROVE BREAST PROST source ↗
Aug 13, 1996 NIH award 1R43GM054440-01 FY1996: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI DURAN, LISE W; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. NUCLEIC ACID IMMOBILIZATION TO MICROTITER WELLS source ↗
Jun 13, 1996 NIH award 2R44HL050224-02 FY1996: $309,180 awarded for that fiscal year; activity R44 (SBIR); PI DUQUETTE, PETER H; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. IMMOBILIZED FATTY ACIDS FOR REVERSIBLE ALBU source ↗
May 27, 1996 NIH award 1R43GM054504-01 FY1996: $96,298 awarded for that fiscal year; activity R43 (SBIR); PI ANDERSON, ARON B; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. NOVEL PHOTOACTIVABLE BIODEGRADABLE TISSUE ADH source ↗
Sep 25, 1995 NIH award 1R43ES007292-01 FY1995: $96,922 awarded for that fiscal year; activity R43 (SBIR); PI GUIRE, PATRICK E; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. PHOTOAFFINITY IMMOBILIZATION OF FUSION PROTEI source ↗
Sep 14, 1995 NIH award 1R43DE011225-01A1 FY1995: $99,998 awarded for that fiscal year; activity R43 (SBIR); PI CLAPPER, DAVID L; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. DENTAL IMPLANT COATINGS TO IMPROVE GINGIVAL source ↗
Aug 31, 1995 NIH award 1R43GM053615-01 FY1995: $99,556 awarded for that fiscal year; activity R43 (SBIR); PI DURAN, LISE W; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. INFECTION-RESISTANT SILVER COATINGS FOR BIOMATER source ↗
Aug 30, 1995 NIH award 1R43AR041612-01A4 FY1995: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI CLAPPER, DAVID L; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. SURFACE MODIFICATION TO IMPROVE OSSEOUS IN source ↗
Jul 31, 1995 NIH award 5R44DK042763-03 FY1995: $288,573 awarded for that fiscal year; activity R44 (SBIR); PI DURAN, LISE W; recipient as written: SURMODICS, INC., EDEN PRAIRIE, MN. SURFACE MODIFYING TO IMPROVE URINARY CATHETER F source ↗

Connect

See your connections at Surmodics on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-18